Cell culture-based production of defective interfering particles for influenza antiviral therapy.

about

Cell culture-based production of defective interfering particles for influenza antiviral therapy.

Item

http://www.wikidata.org/entity/Q47284499

description

2017 nî lūn-bûn

@nan

2017年の論文

@ja

2017年学术文章

@wuu

2017年学术文章

@zh

2017年学术文章

@zh-cn

2017年学术文章

@zh-hans

2017年学术文章

@zh-my

2017年学术文章

@zh-sg

2017年學術文章

@yue

2017年學術文章

@zh-hant

name

Cell culture-based production ...... r influenza antiviral therapy.

@en

Cell culture-based production ...... r influenza antiviral therapy.

@nl

type

Item

label

Cell culture-based production ...... r influenza antiviral therapy.

@en

Cell culture-based production ...... r influenza antiviral therapy.

@nl

prefLabel

Cell culture-based production ...... r influenza antiviral therapy.

@en

Cell culture-based production ...... r influenza antiviral therapy.

@nl

P1476

Cell culture-based production ...... r influenza antiviral therapy.

@en

P2093

Luca Eichwald

http://www.w3.org/2001/XMLSchema#string

Milena A Wasik

http://www.w3.org/2001/XMLSchema#string

Udo Reichl

http://www.w3.org/2001/XMLSchema#string

Yvonne Genzel

http://www.w3.org/2001/XMLSchema#string

P2860

Cloned Defective Interfering Influenza RNA and a Possible Pan-Specific Treatment of Respiratory Virus Diseases

Cloned defective interfering influenza virus protects ferrets from pandemic 2009 influenza A virus and allows protective immunity to be established

Cell culture-based influenza vaccines: A necessary and indispensable investment for the future

Multiscale modeling of influenza A virus infection supports the development of direct-acting antivirals

The pharmacological management of severe influenza infection - 'existing and emerging therapies'.

Influenza virus protecting RNA: an effective prophylactic and therapeutic antiviral.

Continuous cell lines as a production system for influenza vaccines.

Multiple-hit inhibition of infection by defective interfering particles.

A novel broad-spectrum treatment for respiratory virus infections: influenza-based defective interfering virus provides protection against pneumovirus infection in vivo.

Live attenuated influenza viruses produced in a suspension process with avian AGE1.CR.pIX cells.

P2888

s00253-017-8660-3

P304

1167-1177

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1007/S00253-017-8660-3

http://www.w3.org/2001/XMLSchema#string

P407

English

P433

http://www.w3.org/2001/XMLSchema#string

P478

102

http://www.w3.org/2001/XMLSchema#string

P577

2017-12-05T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

29204901

http://www.w3.org/2001/XMLSchema#string

P932

5778153

http://www.w3.org/2001/XMLSchema#string